Carlos M Palmeira Selected Research

1-Naphthylisothiocyanate (1 Naphthylisothiocyanate)

3/2003	Cardiac mitochondrial calcium loading capacity is severely affected after chronic cholestasis in Wistar rats.
1/2003	Reduction in cardiac mitochondrial calcium loading capacity is observable during alpha-naphthylisothiocyanate-induced acute cholestasis: a clue for hepatic-derived cardiomyopathies?
1/2003	Chronic cholestasis and cardiac mitochondrial function in Wistar rats: a model for cardiovascular alterations in chronic liver disease?
7/2002	Improved efficiency of hepatic mitochondrial function in rats with cholestasis induced by an acute dose of alpha-naphthylisothiocyanate.
5/2002	Disruption of mitochondrial calcium homeostasis after chronic alpha-naphthylisothiocyanate administration: relevance for cholestasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos M Palmeira Research Topics

Disease

12	Mitochondrial Diseases (Mitochondrial Disease) 11/2021 - 03/2003
8	Cholestasis 01/2005 - 02/2002
7	Liver Diseases (Liver Disease) 01/2017 - 05/2002
5	Ischemia 01/2022 - 01/2003
5	Hyperglycemia 01/2021 - 05/2004
4	Reperfusion Injury 01/2022 - 07/2020
4	Insulin Resistance 11/2021 - 06/2011
4	Inflammation (Inflammations) 11/2021 - 01/2012
3	Fatty Liver 07/2017 - 12/2008
3	Necrosis 07/2016 - 05/2004
3	Cardiomyopathies (Cardiomyopathy) 01/2005 - 01/2003
2	Obesity 10/2021 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 04/2006
2	Neuroblastoma 01/2019 - 06/2014
2	Parkinson Disease (Parkinson's Disease) 01/2019 - 06/2014
2	Disease Progression 10/2017 - 12/2008
2	Lung Diseases (Lung Disease) 02/2012 - 10/2011
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2003 - 12/2002
1	Edema (Dropsy) 01/2022
1	Hypertriglyceridemia 11/2021
1	Endotoxemia 11/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Hemorrhagic Shock 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2017
1	Memory Disorders (Memory Loss) 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Shock 01/2017
1	Hepatoblastoma 11/2016
1	Hypoxia (Hypoxemia) 12/2015
1	Neoplasms (Cancer) 01/2015
1	Gliosis 06/2014
1	Parkinsonian Disorders (Parkinsonism) 06/2014
1	Carcinoma (Carcinomatosis) 03/2012
1	Non-alcoholic Fatty Liver Disease 01/2012
1	Fibrosis (Cirrhosis) 12/2010
1	Cardiomegaly (Heart Hypertrophy) 12/2010

Drug/Important Bio-Agent (IBA)

6	Bile Acids and Salts (Bile Acids)IBA 10/2021 - 02/2002
6	CalciumIBA 11/2003 - 05/2002
5	AntioxidantsIBA 01/2022 - 01/2003
5	1-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA 03/2003 - 05/2002
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 01/2003
4	Carvedilol (Coreg)FDA LinkGeneric 10/2004 - 12/2002
3	LipidsIBA 11/2021 - 04/2006
3	Fatty Acids (Saturated Fatty Acids)IBA 11/2021 - 06/2011
3	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 04/2006
3	MicroRNAs (MicroRNA)IBA 01/2021 - 09/2014
3	Adenosine Triphosphate (ATP)IBA 01/2019 - 01/2011
3	BilirubinIBA 07/2016 - 05/2002
3	EnzymesIBA 12/2008 - 05/2002
2	Chenodeoxycholic Acid (Chenix)FDA Link 10/2021 - 05/2002
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
2	Sirtuin 3IBA 01/2020 - 12/2010
2	Adenosine Diphosphate (ADP)IBA 01/2019 - 12/2008
2	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 06/2014
2	Oxidopamine (6 Hydroxydopamine)IBA 01/2019 - 06/2014
2	DioxinsIBA 02/2012 - 10/2011
2	Environmental Pollutants (Pollutants, Environmental)IBA 02/2012 - 10/2011
2	FuransIBA 02/2012 - 10/2011
2	Mitochondrial DNA (mtDNA)IBA 12/2007 - 04/2006
2	Biomarkers (Surrogate Marker)IBA 03/2003 - 01/2003
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022
1	Insulin (Novolin)FDA Link 11/2021
1	BiguanidesIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 07/2020
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2019
1	alpha,beta-methyleneadenosine 5'-diphosphateIBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	SilverIBA 01/2018
1	ResveratrolIBA 07/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2017
1	decabromobiphenyl ether (decabromodiphenyl ether)IBA 01/2017
1	GhrelinIBA 01/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	hexabromodiphenyl ether 154IBA 11/2016
1	Transaminases (Aminotransferases)IBA 07/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 07/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2015
1	Apomorphine FDA Link 06/2014
1	coomassie Brilliant BlueIBA 06/2014
1	Purinergic P2X7 ReceptorsIBA 06/2014
1	3- (5- (2,3- dichlorophenyl)- 1H- tetrazol- 1- yl)methylpyridineIBA 06/2014
1	nerolidolIBA 03/2012
1	Sirtuin 1IBA 02/2012
1	BerberineIBA 02/2012
1	Triglycerides (Triacylglycerol)IBA 01/2012
1	Nonesterified Fatty Acids (NEFA)IBA 01/2012
1	CytokinesIBA 01/2012
1	Lysine (L-Lysine)FDA Link 12/2010

Therapy/Procedure

3	Transplantation 01/2022 - 01/2022
3	Therapeutics 10/2017 - 10/2004
2	Liver Transplantation 01/2021 - 01/2017
1	Hepatectomy 01/2017